P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH

• Morag Griffin,
• Jane Humphreys,
• Edward Philpot,
• W. Jason Cummings,
• William Pullman

Affiliations

Morag Griffin

1 St James’s University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Jane Humphreys

2 Omeros Corporation, Seattle, WA, United States

Edward Philpot

2 Omeros Corporation, Seattle, WA, United States

W. Jason Cummings

2 Omeros Corporation, Seattle, WA, United States

William Pullman

2 Omeros Corporation, Seattle, WA, United States